PRESS RELEASE published on 02/27/2024 at 08:00, 8 months 23 days ago PVA TePla exceeds its 2023 sales and earnings targets - Mid-term guidance aims to approximately double sales by 2028 PVA TePla exceeds its 2023 sales and earnings targets, aiming to double sales by 2028. FY 2023 sales over EUR 263 million, EBITDA up 38% to EUR 41 million. Forecast for 2024: Sales to reach EUR 270 - 290 million, EBITDA EUR 47 - 51 million EBITDA Financial Forecast Earnings Sales Targets PVA TePla
BRIEF published on 02/27/2024 at 08:00, 8 months 23 days ago PVA TePla exceeds its sales and results targets in 2023 and plans to double its turnover by 2028 Innovation Sales EBITDA Growth PVA TePla
PRESS RELEASE published on 11/02/2023 at 08:00, 1 year ago PVA TePla: Sales and EBITDA for 2023 expected at upper end of guidance range after strong third quarter
PRESS RELEASE published on 08/03/2023 at 08:00, 1 year 3 months ago PVA TePla Group continues to grow dynamically
PRESS RELEASE published on 06/29/2023 at 09:27, 1 year 4 months ago Annual General Meeting of PVA TePla AG resolves expansion and elects Dr. Myriam Jahn to the Supervisory Board
PRESS RELEASE published on 05/04/2023 at 08:00, 1 year 6 months ago PVA TePla increases sales revenues by 75% in the first quarter, making an outstanding start to the new fiscal year
PRESS RELEASE published on 03/23/2023 at 08:00, 1 year 7 months ago Financial results 2022: PVA TePla shows strong growth in all business areas
PRESS RELEASE published on 03/03/2023 at 09:58, 1 year 8 months ago PVA TePla founder Peter Abel retires
PRESS RELEASE published on 02/27/2023 at 20:29, 1 year 8 months ago EQS-Adhoc: Preliminary figures for fiscal year 2022: PVA TePla significantly exceeds sales and earnings forecast
PRESS RELEASE published on 01/17/2023 at 17:53, 1 year 10 months ago EQS-Adhoc: Supervisory Board of PVA TePla AG appoints CFO as Speaker of the Management Board, CEO leaves the Management Board
Published on 11/21/2024 at 13:00, 30 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 30 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 30 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 15 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
